TILT Biotherapeutics

Oncolytic viruses for solid-tumour immunotherapy (turns 'cold' tumours 'hot'; TILT-123, cytokine-armed adenovirus). Clinical stage.

The row

Sector

Therapeutics & Diagnostics

Stage

Pre-revenue — No sales yet

Location

Helsinki

Founded

2013

Research origin

Univ. of Helsinki

Business ID

2544020-5 · Finnish trade register

Funding

$25.6M (Series B, 2025); >€72M total (company's own statement)

Links

Where this sits on the map

TILT Biotherapeutics is one of 33 companies in Therapeutics & Diagnostics. The others:

How this row was decided

Every row on this map is checked by hand against the trade register and the company's own material, and placed in the sector that best describes its business or its technology. Service firms and consultancies are left out, however advanced the technology they work with — the test is where the revenue comes from. Only funding figures the company or its investor has published are shown. The full rules are on the landscape ↗